Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06085313 · ClinicalTrials.gov registry record · NA

Cancer Pain Management Using a Web-based Intervention

A NA study of Depressive Symptoms and Cancer Pain, sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT06085313: Recruiting NA study of Depressive Symptoms and Cancer Pain, sponsored by University of Texas at Austin.

NCT06085313 is a NA study of Depressive Symptoms and Cancer Pain that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 300 participants, above the 257-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (17% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06085313, a NA study of Depressive Symptoms and Cancer Pain, is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

This study is funded by the HEAL Initiative (https://heal.nih.gov/). Based on Preliminary Studies (PSs), the research team developed and pilot-tested an evidence-based Web App-based information and coaching/support program for cancer pain management (CAPA) that was culturally tailored to Asian American breast cancer survivors using multiple unique features. However, CAPA rarely considered depressive symptoms accompanying pain in its design or components, and PSs indicated the necessity of further individualization of the intervention components of CAPA due to diversities in the needs of ABD. The purpose of the proposed 2-phase study is to further develop CAPA with additional components for ABD and the individual optimization functionality (CAI) and to test the efficacy of CAI in improving cancer pain experience of ABD. The specific aims are to: a) develop and evaluate CAI through an expert review and a usability test (R61 phase); b) determine whether the intervention group (that uses CAI and usual care) will show significantly greater improvements than the active control group (that uses CAPA and usual care) in primary outcomes (cancer pain management and cancer pain experience including depressive symptoms) from baseline to post 1-month and post 3-months; c) identify theory-based variables (attitudes, self-efficacy, perceived barriers, and social influences) that mediate the intervention effects of CAI on the primary outcomes; and d) determine whether the effects of CAI on the primary outcomes are moderated by selected background, disease, genetic, and situational factors. This study is guided by the Bandura's Theory and the stress and coping framework by Lazarus and Folkman. The R61 phase includes: (a) the intervention development process, (b) a usability test among 15 ABD, 15 family members, and 15 community gatekeepers; and (c) an expert review among 10 experts in oncology. The R33 phase adopts a randomized repeated measures control group design among 300 ABD. L

Primary Outcome

1 yes/no question on if cancer pain is managed. If yes, additional questions on cancer pain management (types \[e.g., acetaminophen, NSAIDs, opioid, massage, acupuncture, acupressure, etc.\] and frequency of management \& how much relief). If no, what are the reasons.

Interventions

  • BEHAVIORAL CAI
  • BEHAVIORAL CAPA

Study Locations (1)

Texas

  • The University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-02-20
Est. Completion 2027-08-31
Phase NA
University of Texas at Austin

257 total trials

What NCT06085313 shows while recruiting

NCT06085313 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 257-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (17% higher).

The record links to 3 conditions, with Depressive Symptoms appearing as the primary indexed condition, and to 2 interventions - of which CAI is the first listed.

NCT06085313 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06085313 about?

NCT06085313 is a clinical study titled "Cancer Pain Management Using a Web-based Intervention". This study is funded by the HEAL Initiative (https://heal.nih.gov/). Based on Preliminary Studies (PSs), the research team developed and pilot-tested an evidence-based Web App-based information and coaching/support program for cancer pain management (CAPA) that was culturally tailored to Asian Ameri...

What is the current status of trial NCT06085313?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-02-20. Estimated completion is 2027-08-31.

What conditions does trial NCT06085313 study?

This clinical trial studies the following conditions: Depressive Symptoms, Cancer Pain, Cancer of Breast.

What interventions are being tested in trial NCT06085313?

The interventions under investigation include: CAI (BEHAVIORAL), CAPA (BEHAVIORAL).

Who is sponsoring clinical trial NCT06085313?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06085313 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depressive Symptoms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06085313's enrollment target sits among peer trials

300 10th of 60 higher than 50 of 60 other Depressive Symptoms trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06085313, the US trial registry maintained by the National Library of Medicine. NCT06085313 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.